Immunology and Microbiology
Inflammatory Arthritis
98%
T Cell
55%
Autoimmunity
21%
B Cell
21%
Tyrosine
19%
T Cell Receptor
18%
Methotrexate
17%
Arthritis
17%
Interleukin 10
17%
Autoimmune Disease
14%
Disease-Modifying Antirheumatic Drug
14%
Systemic Lupus Erythematosus
12%
Lymphocyte Function-Associated Antigen 1
11%
Autoantibodies
11%
Regulatory T Cell
11%
TNF Inhibitor
10%
Genetic Risk
10%
T-Helper Cell
9%
Mesenchymal Stem Cell
9%
Immunocompetent Cell
9%
CD3 Antigen
8%
Integrin
8%
Wild Type
8%
Tumor Necrosis Factor Alpha
8%
Single Nucleotide Polymorphism
7%
Immune-Mediated Inflammatory Diseases
7%
Epitope
7%
Cytokine
7%
Lymphocyte
7%
CD25
7%
Abatacept
7%
Immunosuppressive Drug
7%
Gene Expression
7%
Cytokine Production
6%
Macrophage
6%
Interleukin 17
6%
Complement Component 3
6%
Rheumatic Disease
6%
Histocompatibility
5%
COVID-19
5%
STAT3
5%
Pneumococcal Vaccine
5%
Intestine Flora
5%
Preclinical Study
5%
Genome-Wide Association Study
5%
Diapedesis
5%
Osteoblast
5%
Hematopoietic Cell
5%
Regulatory B Cells
5%
CD4
5%
Medicine and Dentistry
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Diseases
22%
COVID-19
20%
Cohort Analysis
16%
Rheumatology
15%
T Cell
14%
Disease Activity
14%
Arthritis
13%
Meta-Analysis
11%
Gout
11%
Odds Ratio
11%
Arm
11%
Randomized Controlled Trial
10%
TNF Inhibitor
10%
Inflammatory Disorder
10%
Urate
10%
Adverse Event
10%
Rheumatic Disease
10%
B Cell
10%
Abatacept
10%
Mental Health
10%
Placebo
9%
Disease Modifying Antirheumatic Drug
9%
Quality of Life
9%
Systematic Review
9%
Pneumococcus Vaccine
8%
Clinical Trial
8%
Methotrexate
8%
Medicine
6%
DAS28
6%
Cohort Effect
6%
Immune-Related Adverse Events
5%
Macrophage
5%
Arthropathy
5%
Comorbidity
5%
Arthralgia
5%
Treatment Response
5%
Monotherapy
5%
Autoantibody
5%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Arthritis
99%
Rheumatoid Arthritis
98%
Diseases
24%
Methotrexate
18%
Placebo
16%
Tumor Necrosis Factor Inhibitor
16%
Arthritis
15%
Adverse Event
14%
Infection
13%
Janus Kinase Inhibitor
12%
Abatacept
12%
Cohort Study
12%
Inflammatory Disease
11%
Disease Modifying Antirheumatic Drug
11%
Clinical Trial
11%
Rheumatic Disease
10%
Coronavirinae
10%
Malignant Neoplasm
9%
Monotherapy
8%
Remission
8%
Autoimmune Disease
7%
Randomized Controlled Trial
7%
Janus Kinase
6%
Comorbidity
5%
Tumor Necrosis
5%
Polyethylene Terephthalate
5%
Polypharmacy
5%
Disease Activity
5%
Arthropathy
5%
Observational Study
5%
Baricitinib
5%
